TFFP insider filings

TFF Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-07-08. Screen TFFP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TFFP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — TFF Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2024-07-084COLEMAN KIRK ALLEN — Chief Financial OfficerGrant/award (A): 10,184 @ $0 · Grant/award (A): 10,184 (derivative) @ $0EDGAR
2024-07-084Mikhak Zamaneh — Chief Medical OfficerGrant/award (A): 10,184 @ $0 · Grant/award (A): 10,184 (derivative) @ $0EDGAR
2024-07-084Weisman Harlan F — President and CEO, DirectorGrant/award (A): 27,480 @ $0 · Grant/award (A): 27,480 (derivative) @ $0EDGAR
2024-07-084Lee Catherine Chai-zon — DirectorGrant/award (A): 1,583 @ $0 · Grant/award (A): 1,583 (derivative) @ $0EDGAR
2024-07-084Roberts Brandi — DirectorGrant/award (A): 3,165 @ $0 · Grant/award (A): 3,165 (derivative) @ $0EDGAR
2024-07-084KING THOMAS BRAXTON — DirectorGrant/award (A): 1,583 @ $0 · Grant/award (A): 1,583 (derivative) @ $0EDGAR
2024-07-084MILLS ROBERT S — DirectorGrant/award (A): 3,165 @ $0 · Grant/award (A): 3,165 (derivative) @ $0EDGAR
2024-07-084ROCAMBOLI STEPHEN — DirectorGrant/award (A): 3,165 @ $0 · Grant/award (A): 3,165 (derivative) @ $0EDGAR
2024-04-224Patane Michael A — DirectorGrant/award (A): 3,556 (derivative) @ $0EDGAR
2024-04-224COLEMAN KIRK ALLEN — Chief Financial OfficerGrant/award (A): 5,300 (derivative) @ $0 · Grant/award (A): 10,600 (derivative) @ $0EDGAR
2024-04-224Mikhak Zamaneh — Chief Medical OfficerGrant/award (A): 5,300 (derivative) @ $0 · Grant/award (A): 10,600 (derivative) @ $0EDGAR
2024-04-224Weisman Harlan F — President and CEO, DirectorGrant/award (A): 44,967 (derivative) @ $0EDGAR
2024-04-224Lee Catherine Chai-zon — DirectorGrant/award (A): 3,556 (derivative) @ $0EDGAR
2024-04-224Roberts Brandi — DirectorGrant/award (A): 5,333 (derivative) @ $0EDGAR
2024-04-224KING THOMAS BRAXTON — DirectorGrant/award (A): 3,110 (derivative) @ $0EDGAR
2024-04-224MILLS ROBERT S — DirectorGrant/award (A): 4,667 (derivative) @ $0EDGAR
2024-04-224ROCAMBOLI STEPHEN — DirectorGrant/award (A): 4,667 (derivative) @ $0EDGAR
2023-12-154KING THOMAS BRAXTON — DirectorGrant/award (A): 132,442 (derivative) @ $0EDGAR
2023-12-044Patane Michael A — DirectorGrant/award (A): 132,442 (derivative) @ $0EDGAR
2023-12-044Lee Catherine Chai-zon — DirectorGrant/award (A): 132,442 (derivative) @ $0EDGAR
2023-12-044Roberts Brandi — DirectorGrant/award (A): 52,858 (derivative) @ $0EDGAR
2023-12-044MILLS ROBERT S — DirectorGrant/award (A): 52,858 (derivative) @ $0EDGAR
2023-12-044ROCAMBOLI STEPHEN — DirectorGrant/award (A): 52,858 (derivative) @ $0EDGAR
2023-08-174CARLSON CAPITAL L P — 10% owner
Double Black Diamond Offshore Ltd — 10% owner
Asgard Investment Corp. II — 10% owner
Carlson Clint Duane — 10% owner
Sale (S): 215,000 @ $0.44 · Sale (S): 1,000 @ $0.39EDGAR
2023-08-154COLEMAN KIRK ALLEN — Chief Financial OfficerPurchase (P): 20,000 @ $0.25EDGAR
2023-08-154Mikhak Zamaneh — Chief Medical OfficerPurchase (P): 120,000 @ $0.25EDGAR
2023-08-154Weisman Harlan F — President and CEO, DirectorPurchase (P): 600,000 @ $0.25EDGAR
2023-08-154Roberts Brandi — DirectorPurchase (P): 20,000 @ $0.25EDGAR
2023-08-154MILLS ROBERT S — DirectorPurchase (P): 40,000 @ $0.25EDGAR
2023-08-154ROCAMBOLI STEPHEN — DirectorPurchase (P): 20,000 @ $0.25EDGAR
2023-03-244COLEMAN KIRK ALLEN — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2023-03-134COLEMAN KIRK ALLEN — Chief Financial OfficerPurchase (P): 12,000 @ $0.79EDGAR
2023-03-134Mikhak Zamaneh — Chief Medical OfficerPurchase (P): 15,000 @ $0.82EDGAR
2023-03-134Weisman Harlan F — President and CEO, DirectorPurchase (P): 150,000 @ $0.88EDGAR
2023-03-134ROCAMBOLI STEPHEN — DirectorPurchase (P): 13,000 @ $0.80EDGAR
2022-12-304Fletcher Aaron G.L. — DirectorGrant/award (A): 33,475 (derivative) @ $0EDGAR
2022-12-304Roberts Brandi — DirectorGrant/award (A): 20,968 (derivative) @ $0EDGAR
2022-12-304MILLS ROBERT S — DirectorGrant/award (A): 33,475 (derivative) @ $0EDGAR
2022-12-304ROCAMBOLI STEPHEN — DirectorGrant/award (A): 33,475 (derivative) @ $0EDGAR
2022-12-194Weisman Harlan F — President and CEO, DirectorPurchase (P): 50,000 @ $1.06EDGAR
2022-12-064Weisman Harlan F — President and CEO, DirectorGrant/award (A): 1,792,450 (derivative) @ $0EDGAR
2022-11-234Fletcher Aaron G.L. — DirectorPurchase (P): 43,470 @ $1.15 · Purchase (P): 21,735 (derivative) @ $0EDGAR
2022-09-304THURMAN RANDY H — DirectorOption exercise (M): 40,255 @ $2.50 · Sale (S): 40,255 @ $4.29 · Option exercise (M): 40,255 (derivative) @ $0EDGAR
2022-05-204Weisman Harlan F — DirectorPurchase (P): 2,500 @ $5.12 · Purchase (P): 4,615 @ $5.50EDGAR
2022-05-174Fletcher Aaron G.L. — DirectorPurchase (P): 85,000 @ $4.86 · Purchase (P): 24,600 @ $5.08EDGAR
2022-05-174COLEMAN KIRK ALLEN — Chief Financial OfficerPurchase (P): 1,250 @ $4.40 · Purchase (P): 425 @ $4.83EDGAR
2022-05-174Mattes Glenn R. — President and CEO, DirectorPurchase (P): 16,000 @ $4.78EDGAR
2022-05-174Weisman Harlan F — DirectorPurchase (P): 2,500 @ $4.74EDGAR
2022-05-174ROCAMBOLI STEPHEN — DirectorPurchase (P): 3,000 @ $4.54EDGAR
2022-04-044Fletcher Aaron G.L. — DirectorPurchase (P): 500,000 @ $6.43 · Purchase (P): 42,000 @ $6.89EDGAR

Recent 8-K events — TFF Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-03-068-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-02-038-K3.02 — Unregistered Sales of Equity Securities
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2024-12-108-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-11-148-K1.02 — Termination of a Material Definitive Agreement
?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-068-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-06-078-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-05-178-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TFFP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs